Epstein-Barr Virus EBV p23 (AA 1-162) Protein

Catalog No. ABIN935324

This Recombinant protein is produced in Escherichia coli (E. coli).

Quick Overview for Epstein-Barr Virus EBV p23 (AA 1-162) Protein (ABIN935324)

Target: Epstein-Barr Virus EBV p23

Protein Type: Recombinant

Origin: Epstein-Barr Virus (EBV)

Source: Escherichia coli (E. coli)

Application: ELISA, Western Blotting (WB)

Purity: > 95 % pure

Product Details

Protein Characteristics: AA 1-162

Characteristics: Purified recombinant EBV p23 protein
Expression System: E.coli

Application Details

Application Notes: Each Investigator should determine their own optimal working dilution for specific applications.

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Supplied as a liquid with 25 mM glycine, pH-9.6, and 50 % glycerol.

Handling Advice: Avoid repeated freeze/thaw cycles.

Storage: RT/-20 °C

Target Details

Target: Epstein-Barr Virus EBV p23

Target Type: Viral Protein

Background: The Epstein-Barr virus (EBV), also called Human herpes virus 4 (HHV-4), is a virusof the herpes family (which includes Herpes simplex virusand Cytomegalo virus. On infecting the B-lymphocyte, the linear virus genome circularizes and the virus subsequently persists within the cell as an episome. The virus can execute several distinct programs of gene expressionwhich can be broadly categorized as being lytic cycle or latent cycle. The lytic cycleor productive infection results in staged expression of a host of viral proteinswith the ultimate objective of producing infectious virions. Formally, this phase of infection does not inevitably lead to lysis of the host cellas EBV virions are produced by budding from the infected cell. The latent cycle(lysogenic) programs are those that do not result in production of virions.
Alternative Names: Epstein-Barr Virus p23 protein, Epstein Barr, EBV HHV4 p123 protein